Roche offers new cardiac, point-of-care diagnostic test

Roche Diagnostics has introduced the Roche Cardiac 200, a testing solution for cardiac diagnostic needs in point-of-care testing environments.

The Roche Cardiac 200, is a lateral flow immunoassay testing system designed to provide quantitative cardiac marker test results on whole blood samples with a turnaround time of only 10 to 19 minutes for emergency department settings, according to the Indianapolis-based company.

Roche said its test can process up to 36 tests per hour and offers a cardiac marker menu that includes NT-proBNP, Troponin I (TnI), CKMB and Myoglobin. The instrument uses a internal corrected fluorescence measurement technology to meet performance expectations of laboratory systems as defined by the National Academy of Clinical Biochemistry (NACB).

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.